Clinical Trial Update: Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma. [Phase 1]

View source ↗

Summary

Open-label Phase 1 study evaluating whether omeprazole affects the pharmacokinetics of Velcade (bortezomib) in patients with advanced solid tumors or Non-Hodgki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• Omeprazole (Omeprazole)
• Velcade (bortezomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Tumors, Non-Hodgkins's Lymphoma | Phase 1 | Status: COMPLETED